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H
 
EPTAHELICAL
 
 receptors, so called because of their
conserved structure featuring seven 
 
a
 
-helical
transmembrane spans, mediate physiological re-
sponses to a remarkably diverse array of stimuli. These in-
clude hormones, neurotransmitters, small peptides, pro-
teins, lipids and ions, as well as sensory stimuli such as
odorants, pheromones, bitter and sweet tastants, and pho-
tons. This superfamily of receptors contains 
 
.
 
1,000 mem-
bers, making it the largest class of cell surface molecules in
the mammalian genome. Moreover, it was found recently
that heptahelical receptors account for 
 
.
 
5% of the total
genes in the 
 
Caenorhabditus elegans
 
 genome (Bargmann,
1998), testifying to the importance of this family and dem-
onstrating that the structure of these receptors has been
highly conserved throughout evolution. For many years,
this family of receptors has been referred to as G protein–
coupled, a term based on the well documented paradigm
that such receptors interact with and signal through het-
erotrimeric G proteins. Simply stated, this repeatedly vali-
dated paradigm is that when heptahelical receptors are
stimulated with ligand, their intracellular regions undergo
conformational changes, allowing the receptors to interact
with G proteins. This association in turn causes conforma-
tional changes in the G proteins that facilitate GDP re-
 
lease and GTP binding, leading to dissociation of G
 
a
 
 and
G
 
bg
 
 subunits. The activated G protein subunits then bind
to and regulate various intracellular effectors.
During the past few years, however, several reports
have appeared in the literature describing various physio-
logical consequences of heptahelical receptor stimulation
that, surprisingly, do not seem to be mediated by G pro-
tein activation. Concurrently, novel techniques for detect-
ing protein–protein interactions such as yeast two-hybrid,
phage display, and fusion protein overlays have revealed
associations of heptahelical receptors with a variety of in-
tracellular partners other than G proteins. This conver-
gence of unexplained physiology and provocative protein–
protein interactions has led increasingly to the realization
that the mechanisms of heptahelical receptor signaling are
more diverse than previously thought. This mini-review
summarizes recent work on the subject of intracellular sig-
naling by heptahelical receptors through means other than
classical G protein pathways.
 
Arrestins and G Protein–coupled Receptor Kinases
 
Activated heptahelical receptors are phosphorylated by a
family of G protein–coupled receptor kinases (GRKs).
 
1
 
Following phosphorylation, the receptors bind to another
family of proteins called arrestins (Lefkowitz, 1998). The
regions of the receptors that arrestins bind to, generally
the third intracellular loop and the portion of the car-
boxyl-terminal tail closest to the membrane, are also pri-
mary determinants for G protein interaction. Arrestin
binding to receptors thus results in desensitization of G
protein–mediated signaling by preventing interaction of
receptors with G proteins. An emerging view, however, is
that the binding of arrestins to heptahelical receptors also
initiates a new set of signaling pathways in addition to
blocking those mediated by G protein activation.
It was proposed recently, for example, that 
 
b
 
-arrestin
can act as an adaptor protein to recruit the tyrosine kinase
 
Src into a signaling complex organized around the 
 
b
 
2
 
-
adrenergic receptor (Luttrell et al., 1999). It is well known
that stimulation of many heptahelical receptors can lead to
the activation of MAP kinases, but the mechanisms in-
volved have been difficult to define. While G protein acti-
vation is clearly necessary, activation of tyrosine kinases of
the Src family is required in many cases as well (Luttrell et
al., 1996). The most recent findings reveal that Src associ-
ates in cells with agonist-activated 
 
b
 
2
 
-adrenergic receptors,
as assessed by immunofluorescence and coimmunoprecip-
itation. The recruitment of cellular Src to 
 
b
 
2
 
-adrenergic re-
ceptors is potentiated by overexpression of 
 
b
 
-arrestin, and
in vitro pull-down studies reveal a direct high-affinity asso-
ciation between Src and 
 
b
 
-arrestin. 
 
b
 
-Arrestin–mediated
association of Src with 
 
b
 
2
 
-adrenergic receptors is a key
step in mitogenic signaling by these receptors, since inhibi-
tion of the binding of 
 
b
 
-arrestin to either the 
 
b
 
2
 
-adrenergic
receptor or Src attenuates 
 
b
 
2
 
-adrenergic activation of
MAP kinase. These results indicate that the association of
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arrestins with heptahelical receptors does not simply un-
couple receptors from G protein pathways, but rather in-
duces a switch in receptor signaling from classical second
messenger–generating G protein–mediated pathways to
other pathways such as those involving Src and leading to
the activation of MAP kinase. Moreover, arrestins have
also been found to interact with a number of cellular pro-
teins involved in endocytosis such as clathrin heavy chain
(Goodman et al., 1996), the clathrin adaptor AP-2 (La-
porte et al., 1999), and NSF (
 
N
 
-ethylmaleimide sensitive
fusion protein) (McDonald et al., 1999). These interac-
tions represent potential mechanisms by which heptaheli-
cal receptors might directly regulate the cellular endocytic
machinery. Thus, arrestins may well represent multifunc-
tional adaptor proteins that mediate a number of aspects
of heptahelical receptor signaling.
GRKs may also be signaling intermediates for heptahe-
lical receptors rather than just proteins involved in recep-
tor desensitization. Recently, it was found that GRK2 can
associate with and phosphorylate tubulin (Carman et al.,
1998; Haga et al., 1998; Pitcher et al., 1998). GRKs have
also been shown to associate with actin (Freeman et al.,
1998) and a novel ARF GTPase-activating protein (ARF
GAP) called GIT1 (Premont et al., 1998). These findings
illustrate at least two ways in which the recruitment of
GRKs to activated heptahelical receptors may lead di-
rectly to cytoskeletal regulation or to modulation of other
intracellular processes: (a) allosteric activation of GRKs
by ligand-occupied receptors (Palczewski et al., 1991;
Chen et al., 1993; Premont et al., 1994) may catalyze the
phosphorylation of key nonreceptor substrates such as tu-
bulin; and (b) GRKs may act as noncatalytic adaptors to
recruit key signaling intermediates (e.g., an ARF GAP)
into complex with the receptors at the plasma membrane.
 
SH2 Domain–containing Signaling Proteins
 
Several subtypes of heptahelical receptors have been pro-
posed to organize SH2 domain–based signaling complexes
in a manner analogous to that seen for receptor tyrosine
kinases. The heptahelical angiotensin AT
 
1
 
 receptor, for
example, activates the Jak2 tyrosine kinase following stim-
ulation with angiotensin II (Marrero et al., 1995). The
mechanism underlying this effect involves Src-mediated
tyrosine phosphorylation of the AT
 
1
 
 receptor itself (Ven-
ema et al., 1998). It is interesting to speculate that this
phosphorylation might result from 
 
b
 
-arrestin–mediated
recruitment of Src to the receptor, but at present this idea
has not been tested. When Tyr319 on the AT
 
1
 
 receptor
carboxyl-terminal tail is phosphorylated, Jak2 coimmuno-
precipitates with the AT
 
1
 
 receptor in an agonist-depen-
dent fashion; mutation of Tyr319 to Phe blocks coim-
munoprecipitation of Jak2 with AT
 
1
 
 receptors and also
attenuates Jak2 activation mediated by angiotensin II
stimulation (Ali et al., 1997). Originally, it was thought
that Jak2 interaction with the AT
 
1
 
 receptor was direct.
Jak2 does not have an SH2 domain, however, so it was not
clear how it could bind to the AT
 
1
 
 receptor tail in a phos-
photyrosine-dependent manner. Subsequent studies re-
vealed that the Jak2/AT
 
1
 
 receptor tail interaction can be
blocked by antibodies to the SHP family of SH2 domain–
containing tyrosine phosphatases (Marrero et al., 1998),
 
indicating that SHP proteins probably act as adaptors to
facilitate the association of Jak2 with the AT
 
1
 
 receptor. It
has also been shown that another SH2 domain–containing
protein, phospholipase C
 
g
 
1, can be coimmunoprecipitated
with the tyrosine-phosphorylated AT
 
1
 
 receptor (Venema
et al., 1998), although the significance of this interaction
for downstream signaling by the receptor has not yet been
clarified.
The 
 
b
 
2
 
-adrenergic receptor is phosphorylated on tyro-
sine by the insulin receptor tyrosine kinase (Hadcock et al.,
1992; Karoor et al., 1995; Valiquette et al., 1995; Bal-
tensperger et al., 1996). Several tyrosines in the 
 
b
 
2
 
-adren-
ergic receptor have been shown to be phosphorylated, and
it has also been reported that the SH2 domain–containing
adaptor protein Grb2 can associate with 
 
b
 
2
 
-adrenergic re-
ceptors following phosphorylation of Tyr350/354 on the
receptor (Karoor et al., 1998). It is not yet known, how-
ever, if this association mediates any downstream signaling
by the 
 
b
 
2
 
-adrenergic receptor. Nonetheless, given these
provocative findings with the AT
 
1
 
 and 
 
b
 
2
 
-adrenergic re-
ceptors, a significant point of future interest will be to see
if other heptahelical receptors may be tyrosine-phos-
phorylated and thus capable of hosting SH2 or PTB do-
main–based signaling complexes.
 
Small GTP-binding Proteins
 
Heptahelical receptor–mediated regulation of small GTP-
binding proteins, such as Ras, Rab, Rho, and ARF, has
been studied for years but has typically been viewed as a
downstream consequence of heterotrimeric G protein ac-
tivation (Buhl et al., 1995; Kozasa et al., 1998). Recently,
however, it has been shown that activation of phospholi-
pase D by certain heptahelical receptors, including M
 
3
 
muscarinic acetylcholine receptors and H
 
1
 
 histamine re-
ceptors, is not blocked by inhibitors of heterotrimeric G
protein pathways, such as pertussis toxin or phospholipase
C inhibitors, but is sensitive to the ARF inhibitor brefeldin
A and the Rho inhibitor C3 botulinum toxin (Mitchell et
al., 1998). ARF and Rho can also be immunoprecipitated
in an agonist-dependent fashion in association with M
 
3
 
muscarinic receptors and AT
 
1
 
 angiotensin receptors. The
receptors capable of binding ARF and Rho exhibit a con-
served motif (N-P-x-x-Y) in their seventh transmembrane
span. Mutation of this motif prevents association of the re-
ceptors with ARF and Rho and also alters receptor signal-
ing to phospholipase D. While it is not clear at present if
the association of ARF and Rho with the heptahelical re-
ceptors is direct, it is clear that these small GTP-binding
proteins can form a complex with some heptahelical re-
ceptors and that formation of this complex can mediate
signaling of these receptors to phospholipase D.
 
PDZ Domain–containing Proteins
 
The heptahelical receptor-binding proteins discussed so
far (heterotrimeric G proteins, arrestins, GRKs, SH2 pro-
teins, and small GTP-binding proteins) all bind to either
the receptor third intracellular loop or the portion of the
receptor tail nearest the plasma membrane. Many hepta-
helical receptors, however, have quite long intracellular
carboxyl-terminal tails, suggesting that the distal portions
of some receptor tails may also be capable of mediating 
Hall et al. 
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association with various intracellular signaling proteins.
Moreover, the carboxyl-terminal tails of some heptahelical
receptors terminate in variants of the T/S-x-V motif re-
quired for binding to PDZ domain–containing proteins
such as PSD-95 (Kornau et al., 1995).
One example of a heptahelical receptor with a long in-
tracellular tail is the 
 
b
 
2
 
-adrenergic receptor. Overlay stud-
ies demonstrated that the tail of this receptor binds with
very high affinity to a single protein in tissue extracts; sub-
sequent purification and sequencing revealed this binding
partner to be a PDZ domain–containing protein, the Na
 
1
 
/
H
 
1
 
 exchanger regulatory factor (NHERF) (Hall et al.,
1998a). NHERF binds not only to the 
 
b
 
2
 
-adrenergic recep-
tor tail in vitro, but also to the full-length 
 
b
 
2
 
-adrenergic re-
ceptor in cells in an agonist-dependent fashion as assessed
by immunofluorescence studies.
 
b
 
2
 
-Adrenergic regulation of renal Na
 
1
 
/H
 
1
 
 exchange has
long been known to be opposite of what would be ex-
pected from a G
 
s
 
-coupled receptor. Activation of G
 
s
 
-cou-
pled receptors such as parathyroid hormone receptors in-
creases cellular cyclic AMP, which in a PKA-dependent
fashion facilitates the association of NHERF with renal
Na
 
1
 
/H
 
1
 
 exchangers and thus leads to inhibition of Na
 
1
 
/H
 
1
 
exchange (Weinman and Shenolikar, 1993). Activation of
 
b
 
2
 
-adrenergic receptors also increases cellular cyclic AMP,
yet paradoxically leads to stimulation of renal Na
 
1
 
/H
 
1
 
 ex-
change (Bello-Reuss, 1980; Weinman et al., 1982). A point
mutant of the 
 
b
 
2
 
-adrenergic receptor with the final residue
of the receptor changed from leucine to alanine, which
cannot bind NHERF but which exhibits normal G protein
coupling, inhibits the activity of the renal Na
 
1
 
/H
 
1
 
 ex-
changer in cells rather than stimulating it like the wild-
type receptor (Hall et al., 1998a). These findings suggest
that the ability of the 
 
b
 
2
 
-adrenergic receptor to bind
NHERF is critical for 
 
b
 
2
 
-adrenergic regulation of renal
Na
 
1
 
/H
 
1
 
 exchange in vivo.
Rhodopsin is another heptahelical receptor that has
been found to associate with a PDZ domain–containing
protein in a functionally relevant manner. Rhodopsin
binds to InaD (Chevesich et al., 1997; Xu et al., 1998), a
multi-PDZ domain scaffolding protein that also associates
with a number of signaling intermediates involved in
rhodopsin-initiated pathways, such as phospholipase C
 
b
 
,
protein kinase C, and the TRP ion channel (Huber et al.,
1996; Shieh and Zhu, 1996; Chevesich et al., 1997; Tsunoda
et al., 1997; Xu et al., 1998). Mutations in InaD profoundly
distort photon-induced rhodopsin signaling (Scott and
Zuker, 1998). The physical association of rhodopsin and
InaD has been demonstrated by coimmunoprecipitation
and by in vitro fusion protein pull-down experiments
(Chevesich et al., 1997; Xu et al., 1998), but it is not known
at present if the association of InaD and rhodopsin in cells
occurs constitutively or if instead it is promoted by photo-
activation of rhodopsin. In any case, it seems that rhodop-
sin can facilitate the assembly of intracellular protein com-
plexes involved in phototransduction via its interaction
with InaD.
The interactions of PDZ domains with the carboxyl ter-
mini of their target proteins are quite specific (Songyang
et al., 1997). As demonstrated by the 
 
b
 
2
 
-adrenergic recep-
tor point mutant, a change of a single amino acid can be
enough to completely disrupt an otherwise high-affinity
association. Only a small number of heptahelical recep-
tors terminate in the carboxyl-terminal motif (S/T-x-L)
required for high-affinity NHERF binding (Hall et al.,
1998b). However, since the 
 
.
 
50 known PDZ domain–con-
taining proteins recognize diverse target motifs, it is prob-
able that some of these proteins associate with specific
heptahelical receptors in a functionally relevant manner.
Signaling through PDZ domain–mediated associations
may therefore be a feature common to many heptahelical
receptors.
 
Polyproline-binding Proteins
 
Several heptahelical receptors exhibit polyproline regions
on either their third intracellular loops or carboxyl-termi-
nal tails. Polyproline regions are known to mediate bind-
ing to a variety of conserved protein domains such as SH3
domains, WW domains, and EVH domains (Pawson and
Scott, 1997). Recently, several subtypes of heptahelical
metabotropic glutamate receptor (mGluR) were shown to
bind members of the Homer family of EVH domain–con-
taining proteins through a polyproline region found in the
mGluR tail region (Brakeman et al., 1997; Tu et al., 1998;
Xiao et al., 1998). This binding has been shown in yeast
two-hybrid studies, fusion protein pull-downs, and coim-
munoprecipitation studies. Some members of the Homer
family can dimerize, and are thus capable of linking
mGluRs to other proteins with appropriate polyproline
motifs. For example, Homer proteins can facilitate a func-
tional interaction between mGluRs and endoplasmic retic-
ulum–based inositol trisphosphate (IP3) receptors, which
control intracellular calcium release. When the mGluR/
Homer association is blocked, the ability of mGluRs to
mobilize intracellular calcium is attenuated (Tu et al.,
1998). These findings suggest that Homer is a key interme-
diate in mGluR regulation of intracellular calcium levels,
and thus shed light on the puzzling observation made
shortly after the cloning of the mGluRs that alternative
splicing of the mGluR1 carboxyl-terminal tail results in
profound differences in the ability of this receptor to mo-
bilize intracellular calcium (Pin et al., 1992; Joly et al.,
1995).
Another heptahelical receptor that can bind signaling
proteins through a polyproline region is the dopamine D4
receptor, which contains a stretch of prolines in its third in-
tracellular loop. This polyproline region in the D4 recep-
tor can mediate in vitro binding to a number of SH3 do-
main–containing proteins, including Grb2 and Nck, as
assessed by yeast two-hybrid and protein pull-down assays
(Oldenhof et al., 1998). It is not clear at present, however,
which polyproline-binding proteins are the relevant cellu-
lar partners for D4 receptors or for other polyproline-con-
taining heptahelical receptors such as 
 
b
 
1
 
-adrenergic recep-
tors and M4 muscarinic receptors. Further work in this
area should reveal which polyproline-binding proteins
couple to which receptors in cells, as well as what the con-
sequences of these interactions are for receptor signaling.
 
Unsolved Heptahelical Receptor Mysteries
 
Several heptahelical receptor binding partners have been
identified for which no clear roles in downstream signaling
have yet been demonstrated. Examples include the in- 
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teraction of Grb2 with the 
 
b
 
2
 
-adrenergic receptor and
dopamine D4 receptor, as described above, as well as
the interaction of the 
 
b
 
2
 
-adrenergic receptor and some
 
a
 
-adrenergic receptor subtypes with the 
 
a
 
 subunit of the
eukaryotic initiation factor 2B (Klein et al., 1997), and the
interaction of the bradykinin B2 receptor with endothelial
nitric oxide synthase (Ju et al., 1998). The recent prolifera-
tion of techniques for detecting protein–protein interac-
tions is likely to lead to an increase in the number of
known binding partners for various heptahelical receptors.
Each of these interactions will represent a new potential
mechanism of heptahelical receptor signaling, although
the true physiological significance of each interaction may
not be immediately obvious.
While such lines of research are describing novel mecha-
nisms by which heptahelical receptors may generate intra-
cellular signals, other lines of research are describing phys-
iological effects mediated by heptahelical receptors for
which the molecular mechanisms are unknown. Genetic
studies in invertebrates, in particular, have yielded a num-
ber of examples of heptahelical receptors mediating physi-
ological actions through pathways that are apparently in-
dependent of G proteins. For instance, the cyclic AMP
receptors of the slime mold 
 
Dictyostelium discoideum
 
 are
heptahelical receptors that induce chemotaxis of undiffer-
entiated 
 
Dictyostelium
 
 cells into an aggregated fruiting
body. These chemotactic effects of 
 
Dictyostelium
 
 cyclic
AMP receptor stimulation are known to be mediated
through G protein activation (Devreotes, 1994). However,
aggregated 
 
Dictyostelium
 
 cells undergo a number of cyclic
AMP receptor–mediated transcriptional changes that are
independent of G protein activation, since cells with G
protein subunits deleted still exhibit these changes follow-
ing stimulation by cyclic AMP (Milne et al., 1995; Schnitz-
ler et al., 1995; Maeda et al., 1996; Jin et al., 1998). The
mechanisms by which this class of heptahelical receptors
might mediate G protein–independent effects, however,
are completely unknown.
More genetic evidence for signaling by heptahelical re-
ceptors through means other than traditional G protein
pathways comes from the study of a family of receptors
known as 
 
frizzled.
 
 In many species, ranging from 
 
C. ele-
gans
 
 to 
 
Drosophila
 
 to mammals, tissue polarity during de-
velopment is regulated by the Wnt family of secreted pro-
teins, which exert their effects on developing cells by
binding to members of the 
 
frizzled
 
 family (Bhanot et al.,
1996; Yang-Snyder et al., 1996; He et al., 1997). Activation
of some 
 
frizzled
 
 family heptahelical receptors results in in-
creases in cellular calcium that can be inhibited by modu-
lators of G protein function such as pertussis toxin and
GDP-
 
b
 
-S (Slusarski et al., 1997). Thus, it seems that 
 
friz-
zled
 
 receptors can couple to G proteins. However, genetic
studies have identified a number of signaling intermedi-
ates downstream of 
 
frizzled
 
, such as 
 
dishevelled
 
, glycogen
synthase kinase-3, 
 
b
 
-catenin, and the product of the ade-
nomatous polyopsis coli (APC) gene (Dale, 1998), and
none of these proteins resemble known components of
classical G protein signaling pathways.
 
Dishevelled
 
 is the most proximal 
 
frizzled
 
 signaling inter-
mediate identified. It is not known if the interaction be-
tween 
 
frizzled
 
 and 
 
dishevelled
 
 is direct, but it is interesting
to note that 
 
dishevelled
 
 contains a PDZ domain and many
 
frizzled
 
 family members possess carboxyl-terminal motifs
appropriate for PDZ domain association. Therefore, it is
possible that members of the 
 
frizzled
 
 family may signal
through direct coupling to PDZ domain–containing pro-
teins like 
 
dishevelled
 
 in a manner analogous to the PDZ
domain–mediated interaction of the 
 
b
 
2
 
-adrenergic recep-
tor with NHERF. Some components of 
 
frizzled
 
 signaling
pathways have been identified as oncogenes in mamma-
lian tissues (Kinzler and Vogelstein, 1996), emphasizing
the importance of understanding 
 
frizzled
 
 signaling.
Another genetically identified heptahelical receptor
that signals via unknown mechanisms is 
 
smoothened.
 
 This
receptor is a relative of the 
 
frizzled
 
 family of receptors,
and is a key mediator of 
 
hedgehog signaling (Alcedo et al.,
1996; van den Heuvel and Ingham, 1996). Hedgehog, a sol-
uble protein first identified as a regulator of patterning
during Drosophila development, binds to a cell surface re-
ceptor known as patched (Chen and Struhl, 1996; Stone
et al., 1996), which leads to regulation of the activity of
smoothened to exert control over cell proliferation and dif-
ferentiation. Since smoothened is a heptahelical receptor,
much attention has been focused on the possibility that it
might couple to heterotrimeric G proteins, but at present
there is no conclusive evidence for such coupling. Indeed,
genetic studies have identified several key proteins, such
as the serine/threonine kinase fused and the putative tran-
scriptional factor cubitus interruptus, as intermediates in
the smoothened signaling pathway; none of these proteins
resemble known components of G protein signaling path-
ways (Ingham, 1998). Activating mutations in the mam-
malian homologue of smoothened have been identified
recently as underlying causes of sporadic basal-cell carci-
noma (Xie et al., 1998), revealing that smoothened, like
frizzled, may be involved in carcinogenesis. The intracellu-
lar signaling mechanisms used by both frizzled and smooth-
ened are thus of interest not just as novel examples of hep-
tahelical receptor signaling, but also as potential points of
clinical intervention in the treatment of some cancers.
Beyond the G Protein Paradigm
Over the past several years, evidence has emerged that
heptahelical receptors can signal through associations with
intracellular partners other than G proteins. In some
cases, these partners are known receptor-interacting pro-
teins, such as arrestins and GRKs, which were thought
previously to be involved only in receptor desensitization.
In other cases, they are novel partners such as NHERF or
Homer, which were not known previously to interact with
heptahelical receptors. For heptahelical receptors that
seem to mediate physiological effects via unknown G pro-
tein–independent pathways, such as frizzled and smooth-
ened, it might be useful to consider analogies with other
heptahelical receptors for which the early steps of various
G protein–independent signaling mechanisms have been
elucidated. Some of these mechanisms are likely to be
quite general: for example, arrestins and GRKs can bind
to many heptahelical receptors, and arrestin- and GRK-
mediated formation of signaling complexes may therefore
be a feature common to many heptahelical receptors.
Other mechanisms, such as the activation of small GTP-
binding proteins or the formation of SH2-based signalingHall et al. Heptahelical Receptor Signaling: Beyond the G Protein Paradigm 931
complexes organized around tyrosine-phosphorylated res-
idues, may be relevant to a small number of heptahelical
receptors but not to the majority. Still other mechanisms
are likely to be highly receptor-specific: the binding of
NHERF to the b2-adrenergic receptor and the binding of
Homer to metabotropic glutamate receptors, for example,
depend on the presence of precise motifs that are likely to
be found in few other heptahelical receptors, although
other receptors are likely to contain slightly modified mo-
tifs that mediate binding to other specific PDZ or polypro-
line-binding domains.
There are .1,000 heptahelical receptors but only z20
different heterotrimeric G proteins. Such an arrangement
would seem to place limitations on the specificity of hepta-
helical receptor signal transduction, if G proteins were the
only mediators of heptahelical receptor–initiated signal-
ing. However, it now seems likely that each heptahelical
receptor may activate its own relatively specific set of in-
tracellular signaling pathways, including both G protein–
dependent and G protein–independent mechanisms (Fig.
1). The net physiological effect of stimulation of a particu-
lar heptahelical receptor will thus reflect the sum of the
various intracellular pathways it can activate, with some of
the pathways being quite general, others being fairly spe-
cific, and some being unique to the individual receptor.
The near future is likely to yield a number of new ex-
amples of heptahelical receptor signaling through means
other than classical G protein pathways. Some of these
new receptor-initiated signaling pathways may be varia-
tions on a theme already seen in other heptahelical recep-
tors, while others are likely to be completely novel. In any
case, the old view of heptahelical receptors as simple G
protein activators is currently being replaced by a new
view of these receptors as complicated signal-transducing
machines capable of directly coupling to a host of intracel-
lular signaling pathways.
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